– postpartum placenta: the foundation of our science – celularity scientists were the first to recognize the human placenta as an untapped resource for innovation, one which is the basis of celularity innovations in immuno-oncology, hematology, and regenerative medicine. our seminal discovery of unique stem, progenitor, and immune cells from the placenta is the foundation of our dominating intellectual property position. with proprietary platform technology and operational expertise to harness the power of this remarkable organ, we developed a deep therapeutic pipeline across a broad range of indications. – amplifying the body’s ability to regenerate – celularity combines innovative assets and research in cell therapy, functional regeneration, and biosourcing to develop leading therapeutic products and services that treat serious, life-threatening diseases. we are harnessing the unique cells and biomaterials from the postpartum placenta to provide therapies that amplify the body’s abil